Ángel Santos‐Briz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ángel Santos‐Briz has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
- Javier Cañueto
Department of Dermatology, Complejo Asistencial Universitario de Salamanca (CAUSA) and Instituto de Investigación Biomédica of Salamanca (IBSAL) and Faculty of Medicine, University of Salamanca, Salamanca, Spain
6 shared publications - David Revilla‐Nebreda
Department of Dermatology University Hospital of Salamanca Salamanca Spain
3 shared publications - Alberto Conde-Ferreirós
Department of Dermatology Complejo Asistencial Universitario de Salamanca Salamanca Spain
2 shared publications - José María Mir-Bonafé
Department of Dermatology, Juaneda Hospital, Spain
2 shared publications - Luis Requena
Department of Dermatology Hospital Universitario Fundación Jiménez Díaz Madrid Spain
2 shared publications M. Yuste-Chaves
Departamento de Dermatología. Hospital Universitario de Salamanca, España
2 shared publications
Latest Publications
- 31 August 2026
- Published by Wiley in Australasian Journal of Dermatology
Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma With Unusual Clinicopathological Characteristics: A Study of Three Patients With Molecular Characterization
Primary cutaneous gamma‐delta T‐cell lymphoma (PCGDTCL) is a rare cytotoxic lymphoma with considerable clinicopathological heterogeneity. We report three patients with unusual presentations, including a TCR‐silent phenotype with spontaneous regression followed by rapid progression, a granulomatous variant with a prolonged indolent course, and a lupus panniculitis‐like form. Molecular studies demonstrated persistent clonal disease and identified recurrent alterations involving TET2 , STAT3 , CDKN2A , MAPK1 , PDCD1 and TNFAIP3 , with acquisition of additional mutations during disease evolution. These cases expand the recognized spectrum of PCGDTCL and highlight the importance of integrating clinicopathological and molecular findings in diagnostically challenging presentations.
- 31 August 2026
- Published by Wiley in Australasian Journal of Dermatology
Primary Cutaneous Gamma‐Delta T‐Cell Lymphoma With Unusual Clinicopathological Characteristics: A Study of Three Patients With Molecular Characterization
Primary cutaneous gamma‐delta T‐cell lymphoma (PCGDTCL) is a rare cytotoxic lymphoma with considerable clinicopathological heterogeneity. We report three patients with unusual presentations, including a TCR‐silent phenotype with spontaneous regression followed by rapid progression, a granulomatous variant with a prolonged indolent course, and a lupus panniculitis‐like form. Molecular studies demonstrated persistent clonal disease and identified recurrent alterations involving TET2 , STAT3 , CDKN2A , MAPK1 , PDCD1 and TNFAIP3 , with acquisition of additional mutations during disease evolution. These cases expand the recognized spectrum of PCGDTCL and highlight the importance of integrating clinicopathological and molecular findings in diagnostically challenging presentations.
- Open Access
- 22 December 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (2) , 564-566
Absence of HPV in Verrucous Psoriasis Lesions
- 22 December 2024
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (2) , 564-566
Open AccessAbsence of HPV in Verrucous Psoriasis Lesions
- 27 March 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (11) , e923-e925
‘Vasculitis‐like’ damage due to micropunch in follicular unit excision hair transplantation surgery: Ten cases
- 27 March 2024
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 38 (11) , e923-e925
‘Vasculitis‐like’ damage due to micropunch in follicular unit excision hair transplantation surgery: Ten cases
- 21 August 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 50 (11) , 983-990
Pancreatic panniculitis revisited: A series of 34 patients
Background: Pancreatic panniculitis is a rare form of panniculitis generally associated with acute or chronic pancreatitis, and less frequently with pancreatic carcinoma. Clinically, it presents with subcutaneous nodules usually located in the lower extremities, however, it presents an almost pathognomonic histopathological finding with enzymatic fat necrosis in the adipose tissue.Methods: In this retrospective case series of five hospitals, biopsy specimens of cutaneous lesions of pancreatic panniculitis were reviewed. Clinical information was obtained through medical records.Results: A total of 34 cases were included, 23 women and 11 men, aged between 31 and 92 years. The most common associated pancreatic disease was acute pancreatitis (23 cases) and its main triggering cause was gallstones (17 cases). In two patients it was related to chronic pancreatitis and six cases were associated with malignancy. Histopathological findings were always the key to diagnosis. In the biopsies reviewed, mostly lobular panniculitis with the characteristic necrosis of the adipocytes was observed. In addition, nine of the cases presented with Splendore–Hoeppli phenomenon.Conclusions: We present the largest series of pancreatic panniculitis. Clinically, the female predominance and biliary lithiasis as the main cause of acute pancreatitis are to be emphasized. Histopathologically, a peripheral eosinophilic striated rim surrounding aggregates of ghost adipocytes consistent with Splendore–Hoeppli is an additional clue to its diagnosis.
- 21 August 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 50 (11) , 983-990
Pancreatic panniculitis revisited: A series of 34 patients
Background: Pancreatic panniculitis is a rare form of panniculitis generally associated with acute or chronic pancreatitis, and less frequently with pancreatic carcinoma. Clinically, it presents with subcutaneous nodules usually located in the lower extremities, however, it presents an almost pathognomonic histopathological finding with enzymatic fat necrosis in the adipose tissue.Methods: In this retrospective case series of five hospitals, biopsy specimens of cutaneous lesions of pancreatic panniculitis were reviewed. Clinical information was obtained through medical records.Results: A total of 34 cases were included, 23 women and 11 men, aged between 31 and 92 years. The most common associated pancreatic disease was acute pancreatitis (23 cases) and its main triggering cause was gallstones (17 cases). In two patients it was related to chronic pancreatitis and six cases were associated with malignancy. Histopathological findings were always the key to diagnosis. In the biopsies reviewed, mostly lobular panniculitis with the characteristic necrosis of the adipocytes was observed. In addition, nine of the cases presented with Splendore–Hoeppli phenomenon.Conclusions: We present the largest series of pancreatic panniculitis. Clinically, the female predominance and biliary lithiasis as the main cause of acute pancreatitis are to be emphasized. Histopathologically, a peripheral eosinophilic striated rim surrounding aggregates of ghost adipocytes consistent with Splendore–Hoeppli is an additional clue to its diagnosis.
- 9 August 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 50 (11) , 935-937
Cutaneous metastasis of mixed neuroendocrine, sarcomatous, and squamous rectal carcinoma mimicking a Merkel cell polyomavirus‐negative Merkel cell carcinoma
- 9 August 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 50 (11) , 935-937
Cutaneous metastasis of mixed neuroendocrine, sarcomatous, and squamous rectal carcinoma mimicking a Merkel cell polyomavirus‐negative Merkel cell carcinoma
- 3 December 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (4) , E474-E478
TMeB score may improve risk stratification of high‐risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study
- 3 December 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (4) , E474-E478
TMeB score may improve risk stratification of high‐risk cutaneous squamous cell carcinoma and guide management of patients: A pilot study
- 7 August 2021
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (2) , 133-138
Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case‐control study
Background: Acantholytic cutaneous squamous cell carcinomas (aCSCCs) have been classically considered as a high‐risk variant of CSCC. However, more recent studies show that aCSCC does not confer more aggressiveness. This study aims to establish whether the prognosis of the aCSCC is worse than that of the non‐acantholytic (naCSCC) or not.Methods: Retrospective case‐control study with 50 aCSCCs and 50 naCSCCs. For each aCSCC, an naCSCC with similar high‐risk features to the aCSCC but with no acantholysis was selected. Prognosis between both groups was compared.Results: The mean age was 86 years (SD 9.61). Sixty‐one patients were men. Thirty‐nine CSCCs were located in high‐risk head and neck areas. Twenty CSCCs exhibited a poor degree of differentiation, and 36 showed an infiltrative growth pattern. The tumor diameter was 18.71 mm (interquartile range, IQR 35), and the tumor thickness was 6.72 mm (IQR 15.50). Twelve CSCCs exhibited perineural infiltration, and eight CSCCs exhibited invasion beyond the subcutaneous fat. Positive margins after excision of the tumor in 22 aCSCCs vs eight naCSCCs (P < 0.02). Nineteen poor‐prognosis events were observed (local recurrence, lymph node metastasis, and death from CSCC). However, no differences were observed between both groups when comparing poor‐prognosis events.Conclusion: The proportion of unfavorable events is similar in aCSCC and naCSCC. The acantholytic histopathological subtype is not associated with a poorer prognosis than the non‐acantholytic CSCC in our cohort.
- 7 August 2021
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 49 (2) , 133-138
Clinical and histopathological evaluation of 50 acantholytic cutaneous squamous cell carcinomas: Analysis outcome in a retrospective case‐control study
Background: Acantholytic cutaneous squamous cell carcinomas (aCSCCs) have been classically considered as a high‐risk variant of CSCC. However, more recent studies show that aCSCC does not confer more aggressiveness. This study aims to establish whether the prognosis of the aCSCC is worse than that of the non‐acantholytic (naCSCC) or not.Methods: Retrospective case‐control study with 50 aCSCCs and 50 naCSCCs. For each aCSCC, an naCSCC with similar high‐risk features to the aCSCC but with no acantholysis was selected. Prognosis between both groups was compared.Results: The mean age was 86 years (SD 9.61). Sixty‐one patients were men. Thirty‐nine CSCCs were located in high‐risk head and neck areas. Twenty CSCCs exhibited a poor degree of differentiation, and 36 showed an infiltrative growth pattern. The tumor diameter was 18.71 mm (interquartile range, IQR 35), and the tumor thickness was 6.72 mm (IQR 15.50). Twelve CSCCs exhibited perineural infiltration, and eight CSCCs exhibited invasion beyond the subcutaneous fat. Positive margins after excision of the tumor in 22 aCSCCs vs eight naCSCCs (P < 0.02). Nineteen poor‐prognosis events were observed (local recurrence, lymph node metastasis, and death from CSCC). However, no differences were observed between both groups when comparing poor‐prognosis events.Conclusion: The proportion of unfavorable events is similar in aCSCC and naCSCC. The acantholytic histopathological subtype is not associated with a poorer prognosis than the non‐acantholytic CSCC in our cohort.
- Open Access
- 2 August 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (11) , E747-E749
New‐onset acral lesions on hands after administration of mRNA‐1273 vaccine against SARS‐CoV‐2: clinical images and histopathological study of three cases
- 2 August 2021
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 35 (11) , E747-E749
Open AccessNew‐onset acral lesions on hands after administration of mRNA‐1273 vaccine against SARS‐CoV‐2: clinical images and histopathological study of three cases
- 25 March 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (3) , 551-558
TERT promoter mutation in sebaceous neoplasms
TERT promoter (TERTp) mutations widely occur in multiple human neoplasms, and they have been related to different clinicopathological features. To date, this mutation has not been identified in sebaceous tumors. Here, we analyzed TERTp mutations in 91 sebaceous neoplasms (17 adenomas, 45 sebaceomas, and 29 carcinomas). We detected mutations in 26.7% (8 of 29) of sebaceous carcinomas by pyrosequencing and Sanger sequencing. No mutation was detected in adenomas or sebaceomas. The difference was significant between sebaceoma and carcinoma. The most frequent TERTp mutations were C228T and C250T in 37.5% (3 of 8) of mutated cases each one. The mutation was not associated with poor clinical evolution. Using NGS, 20 of 29 (68.5%) sebaceous carcinomas harbored mutations in 8 of the 30 genes analyzed (TP53, TERTp, EGFR, ATRX, PDGFRA, CDKN2A, PTEN, and ACVR1). With immunohistochemistry, only 1 of 8 (12.5%) TERTp-mutated carcinomas lacked mismatch repair (MMR) protein expression compared to 6 of 21 (31.6%) of non-mutated ones. Sebaceous carcinomas with MMR protein expression had significantly higher frequency of total mutations and TP53 and TERTp mutations than MMR protein-deficient carcinomas. In conclusion, TERTp mutation has been detected in sebaceous carcinomas, and its presence could be useful to differentiate sebaceous carcinoma from sebaceoma, a difficult histopathological challenge.
- 25 March 2021
- Published by Springer Nature in Virchows Archiv
- Vol. 479 (3) , 551-558
TERT promoter mutation in sebaceous neoplasms
TERT promoter (TERTp) mutations widely occur in multiple human neoplasms, and they have been related to different clinicopathological features. To date, this mutation has not been identified in sebaceous tumors. Here, we analyzed TERTp mutations in 91 sebaceous neoplasms (17 adenomas, 45 sebaceomas, and 29 carcinomas). We detected mutations in 26.7% (8 of 29) of sebaceous carcinomas by pyrosequencing and Sanger sequencing. No mutation was detected in adenomas or sebaceomas. The difference was significant between sebaceoma and carcinoma. The most frequent TERTp mutations were C228T and C250T in 37.5% (3 of 8) of mutated cases each one. The mutation was not associated with poor clinical evolution. Using NGS, 20 of 29 (68.5%) sebaceous carcinomas harbored mutations in 8 of the 30 genes analyzed (TP53, TERTp, EGFR, ATRX, PDGFRA, CDKN2A, PTEN, and ACVR1). With immunohistochemistry, only 1 of 8 (12.5%) TERTp-mutated carcinomas lacked mismatch repair (MMR) protein expression compared to 6 of 21 (31.6%) of non-mutated ones. Sebaceous carcinomas with MMR protein expression had significantly higher frequency of total mutations and TP53 and TERTp mutations than MMR protein-deficient carcinomas. In conclusion, TERTp mutation has been detected in sebaceous carcinomas, and its presence could be useful to differentiate sebaceous carcinoma from sebaceoma, a difficult histopathological challenge.
- Open Access
- 1 March 2021
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 112 (3) , 259-260
La bandera roja: fenómeno de Meyerson en el melanoma maligno
- 1 March 2021
- Published by Elsevier in Actas Dermo-Sifiliograficas
- Vol. 112 (3) , 259-260
Open AccessLa bandera roja: fenómeno de Meyerson en el melanoma maligno